Congestive heart insufficiency and angiotensin converting enzyme inhibitors
Clara, J.G.
Revista Portuguesa de Cardiologia Orgao Oficial da Sociedade Portuguesa de Cardiologia 8(7-8): 553-557
1989
ISSN/ISBN: 0870-2551 PMID: 2698719 Document Number: 336247
Document emailed within 1 workday
Related Documents
Squire, I.B.; MacFayden, R.J.; Reid, J.L.; Devlin, A.; Lees, K.R. 1996: Differing early blood pressure and renin-angiotensin system responses to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure Journal of Cardiovascular Pharmacology 27(5): 657-666Kolber-Postepska, B. 1992: Treatment of chronic congestive heart failure using angiotensin converting enzyme inhibitors Wiadomosci Lekarskie 45(23-24): 903-906
Thilly, N.; Zannad, Fïez.; Dufay, E.; Juillière, Y.; Briançon, S. 2003: Angiotensin-converting enzyme inhibitors in congestive heart failure: clinical practice guidelines Therapie 58(4): 341-349
Ghali, J.K.; Giles, T.; Gonzales, M.; Horswell, R.; Kumar, S.; Lejuene, A.; Livaudais, G.F.; Sarkar, I.C. 1997: Patterns of physician use of angiotensin converting enzyme inhibitors in the inpatient treatment of congestive heart failure Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 149(12): 474-484
Nony, P.; Boissel, J.P.; Girard, P.; Leizorovicz, A.; Lievre, M.; Chifflet, R. 1992: Relative efficacy of angiotensin converting enzyme inhibitors on mortality of patients with congestive heart failure: implications of randomized trials and role of the aetiology (ischaemic or non-ischaemic) of heart failure European Heart Journal 13(8): 1101-1108
Amodeo, C. 1990: Inhibitors of angiotensin-converting enzyme in cardiac insufficiency Arquivos Brasileiros de Cardiologia 54(2): 97-99
Correia, J.F. 1991: Therapy of cardiac insufficiency with angiotensin converting enzyme inhibitors. new concepts-new strategies Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 10(11): 851-857
Sami, M.H. 1994: Distinctive properties of perindopril among converting enzyme inhibitors in congestive heart failure Canadian Journal of Cardiology 10 Suppl D: 13d-16d
Voronkov, L.G.; Serdiuk, T.E.; Riabenko, D.V. 2000: Use of inhibitors of the angiotensin-converting enzyme and the beta-adrenoblocker metoprolol combined in treatment of chronic cardiac insufficiency Likars'ka Sprava 2000(7-8): 77-80
Correia, J.F. 1992: Treatment of heart insufficiency in the elderly with converting enzyme inhibitors Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(11): 969-984
Rudolf, W.; Froer, K.L.; Hall, D. 1982: New drug preparations used for treating congestive heart failure: converting enzyme inhibitors, nitroprusside, nitrates and calcium channel blockers Terapevticheskii Arkhiv 54(11): 110-112
Olinic, N.; Vida-Simiti, L.; Cristea, A.; Mureşan, A.; Pop, S.; Teşanu, E. 1994: Correlation between fibronectin and cardiothoracic ratio in heart failure treated with angiotensin converting enzyme inhibitors Romanian Journal of Internal Medicine 32(4): 253-257
Mareev, V.I.; Lopatin, I.M.; Dzhakhangirov, T.S.; Gkhani, P.; Ageev, F.T.; Belenkov, I.N. 1993: Comparative study on use of angiotensin-converting enzyme inhibitors and cardiac glycosides in the treatment of cardiac insufficiency Kardiologiia 33(12): 23-31; 3-4
Ganten, D.; Mullins, J.; Lindpaintner, K. 1989: The tissue renin-angiotensin system: a target for angiotensin-converting enzyme inhibitors Journal of Human Hypertension 3(Suppl 1): 63-70
De Paz, S.; Martín, A.B.; Iglesias, A.; Domínguez, A.R. 1999: Angioedema-urticaria caused by angiotensin-converting enzyme inhibitors and angiotensin Ii receptor antagonists Medicina Clinica 113(19): 759
Jover, B.; Mimran, A. 1994: Angiotensin II receptor antagonists versus angiotensin converting enzyme inhibitors: effects on renal function Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 12(9): S3-S9
Krzesinski, J.M.; Montrieux, C.; Scheen, A.J. 2006: Angiotensin converting enzyme inhibitors or angiotensin Ii receptor blocker in cardiovascular and renal pathology in 2006: what does EBM teach us? Revue Medicale de Liege 61(5-6): 414-422
Surabenjawong, U.; Thunpiphat, N.; Chatsiricharoenkul, S.; Monsomboon, A. 2013: Prevalence of hyperkalemia in adult patients taking spironolactone and angiotensin converting enzyme inhibitors or angiotensin receptor blockers Journal of the Medical Association of Thailand 96(8): 905-910
Wang, L.; Cai, S.-r.; Zhang, C.-h.; He, Y.-l.; Zhan, W.-h.; Wu, H.; Peng, J.-j. 2008: Effects of angiotensin converting enzyme inhibitors and angiotensin Ii receptor blockers on angiogenesis of gastric cancer in a nude mouse model Zhonghua Wei Chang Wai Ke Za Zhi 11(6): 565-568
McMurray, J.J. 1998: Failure to practice evidence-based medicine: why do physicians not treat patients with heart failure with angiotensin-converting enzyme inhibitors? European Heart Journal 19(Suppl): L15-L21